VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KALA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KALAKALA BIO, Inc.
$2.09$46M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKALAQuarterly Financials

KALA BIO, Inc. (KALA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

KALA BIO, Inc. (KALA) quarterly income statement — complete revenue, gross profit & net income history

KALA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000420K2.1M1.37M1.86M3.07M3.05M
Revenue Growth %-----------100%-100%-100%-100%-86.31%-31.17%-57.99%-17.07%38.15%266.27%
Cost of Goods Sold054K00069K63K61K66K70K157K77K87K-169K180K1.77M775K1.42M908K1.02M
COGS % of Revenue--------------42.86%84.48%56.49%76.4%29.61%33.3%
Gross Profit0-54K000-69K-63K-61K-66K-70K-157K-77K-87K169K240K326K597K438K2.16M2.04M
Gross Margin %--------------57.14%15.52%43.51%23.6%70.39%66.7%
Gross Profit Growth %-21.74%100%100%100%1.43%59.87%20.78%24.14%-141.42%-165.42%-123.62%-114.57%-61.42%-88.88%-83.98%-73.62%-33.03%64.56%423.53%
Operating Expenses1.8M10.17M7.24M11.03M10.67M9.39M9.51M9.57M11.71M9.27M10.35M9.16M9.98M9.32M14.77M27.15M31.45M26.44M28.23M31.08M
OpEx % of Revenue--------------3516.9%1292.67%2292.13%1424.62%920.44%1018.68%
Selling, General & Admin1.74M9.86M4.53M4.64M4.59M4.2M4.4M4.32M5.36M4.55M4.79M4.96M5.94M6M9.38M22.67M26.98M24.03M25.35M27.99M
SG&A % of Revenue--------------2233.33%1079.67%1966.62%1294.56%826.51%917.27%
Research & Development61K312K6.13M6.23M6.05M5.19M5.11M5.26M6.35M4.72M5.55M4.2M4.04M3.32M5.39M4.47M4.47M2.41M2.88M3.09M
R&D % of Revenue--------------1283.57%213%325.51%130.06%93.94%101.41%
Other Operating Expenses00-1000K153K21K000000000000000
Operating Income-1.8M-10.22M-7.24M-11.03M-10.67M-9.46M-9.57M-9.63M-11.77M-9.34M-10.51M-9.24M-10.07M-9.15M-14.53M-26.82M-30.85M-26M-26.07M-29.05M
Operating Margin %---------------3459.76%-1277.14%-2248.62%-1401.02%-850.05%-951.98%
Operating Income Growth %83.11%-8.1%24.34%-14.47%9.38%-1.26%8.93%-4.26%-16.96%-2.04%27.7%65.55%67.37%64.8%44.26%7.66%-8.96%10.29%-0.89%-36.49%
EBITDA-1.8M-10.17M-7.11M-10.96M-10.6M-9.39M-9.51M-9.57M-11.71M-9.27M-10.35M-9.16M-9.98M-9.17M-14.36M-26.45M-30.51M-26M-25.22M-28.2M
EBITDA Margin %---------------3419.52%-1259.48%-2223.98%-1401.02%-822.27%-924.29%
EBITDA Growth %83%-8.32%25.19%-14.5%9.45%-1.28%8.16%-4.47%-17.32%-1.08%27.94%65.36%67.3%64.73%43.05%6.21%-10.81%7.97%-0.33%-37.05%
D&A (Non-Cash Add-back)054K128K67K68K69K63K61K66K70K157K77K87K-18K169K371K338K0852K845K
EBIT-1.8M-10.22M-6.6M-10.07M-7.86M-9.46M-9.57M-9.63M-11.77M-9.34M-10.51M-9.24M-10.07M-9.15M-14.53M-26.82M-30.85M-26M-26.07M-29.05M
Net Interest Income74K-141K-693K-674K-628K-914K-908K-954K-951K-858K-751K-695K-799K-1.22M-1.21M-2.14M-2.03M-2.06M-2.06M-2.06M
Interest Income74K0270K407K463K478K570K504K504K610K708K718K675K354K234K68K8K12K16K33K
Interest Expense0141K963K1.08M1.09M1.39M1.48M1.46M1.46M1.47M1.46M1.41M1.47M1.58M1.45M2.21M2.04M2.08M2.07M2.09M
Other Income/Expense181K10.91M-325K-127K1.72M1.28M618K55K-34K714K1.8M-1.17M-4.39M-3.69M43.6M-1.29M-2.09M-21.57M-2.06M-7.45M
Pretax Income-1.62M686K-7.56M-11.15M-8.95M-8.18M-8.95M-9.58M-11.81M-8.63M-8.7M-10.41M-14.46M-12.84M29.07M-28.11M-32.94M-47.57M-28.13M-36.5M
Pretax Margin %--------------6922.14%-1338.62%-2400.95%-2562.93%-917.09%-1196.26%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.62M686K-7.56M-11.15M-8.95M-8.18M-8.95M-9.58M-11.81M-8.63M-8.7M-10.41M-14.46M-12.84M29.07M-28.11M-32.94M-47.57M-28.13M-36.5M
Net Margin %--------------6922.14%-1338.62%-2400.95%-2562.93%-917.09%-1196.26%
Net Income Growth %81.88%108.39%15.49%-16.45%24.22%5.24%-2.83%8.01%18.32%32.83%-129.94%62.96%56.12%73%203.36%22.98%-8.32%-52.89%-0.64%-56.56%
Net Income (Continuing)-1.62M686K-7.56M-11.15M-8.95M-8.18M-8.95M-9.58M-11.81M-8.63M-8.7M-10.41M-14.46M-12.84M29.07M-28.11M-32.94M-47.57M-28.13M-36.5M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.200.08-1.07-1.71-1.41-1.74-1.93-3.16-4.20-3.18-3.41-4.36-6.99-7.8219.25-18.50-22.41-36.56-21.41-28.27
EPS Growth %85.82%104.84%44.56%45.89%66.43%45.28%43.4%27.52%39.91%59.34%-117.71%76.43%68.81%78.61%189.91%34.56%9.12%-33.77%14.15%-35.13%
EPS (Basic)-0.200.08-1.07-1.71-1.41-1.74-1.93-3.16-4.20-3.18-3.41-4.36-6.99-7.9619.39-18.50-22.41-36.56-21.62-28.27
Diluted Shares Outstanding8.15M8.15M7.04M6.51M6.35M4.69M4.63M3.03M2.81M2.71M2.55M2.39M2.07M1.52M1.51M1.47M1.47M1.3M1.31M1.29M
Basic Shares Outstanding8.15M8.15M7.04M6.51M6.35M4.69M4.63M3.03M2.81M2.71M2.55M2.39M2.07M1.52M1.5M1.47M1.47M1.3M1.3M1.29M
Dividend Payout Ratio--------------------